INS and diabetes mellitus: For instance, in diabetes, abnormal m6A modifications on the mRNA of genes involved in key metabolic pathways may lead to changes in the expression of proteins related to insulin secretion, subsequently affecting blood glucose metabolism [21, 22, 23].